New Dual Small Molecules for Alzheimer’s Disease Therapy Combining Histamine H3Receptor (H3R) Antagonism and Calcium Channels Blockade with Additional Cholinesterase Inhibition

MLA

Malek, Rim, et al. “New Dual Small Molecules for Alzheimer’s Disease Therapy Combining Histamine H3Receptor (H3R) Antagonism and Calcium Channels Blockade with Additional Cholinesterase Inhibition.” Journal of Medicinal Chemistry, vol. 62, no. 24, Dec. 2019, pp. 11416–22. EBSCOhost, https://doi.org/10.1021/acs.jmedchem.9b00937.

APA

Malek, R., Arribas, R. L., Palomino-Antolin, A., Totoson, P., Demougeot, C., Kobrlova, T., Soukup, O., Iriepa, I., Moraleda, I., Diez-Iriepa, D., Godyń, J., Panek, D., Malawska, B., Głuch-Lutwin, M., Mordyl, B., Siwek, A., Chabchoub, F., Marco-Contelles, J., Kiec-Kononowicz, K., … Ismaili, L. (2019). New Dual Small Molecules for Alzheimer’s Disease Therapy Combining Histamine H3Receptor (H3R) Antagonism and Calcium Channels Blockade with Additional Cholinesterase Inhibition. Journal of Medicinal Chemistry, 62(24), 11416–11422. https://doi.org/10.1021/acs.jmedchem.9b00937

Chicago

Malek, Rim, Raquel L. Arribas, Alejandra Palomino-Antolin, Perle Totoson, Celine Demougeot, Tereza Kobrlova, Ondrej Soukup, et al. 2019. “New Dual Small Molecules for Alzheimer’s Disease Therapy Combining Histamine H3Receptor (H3R) Antagonism and Calcium Channels Blockade with Additional Cholinesterase Inhibition.” Journal of Medicinal Chemistry 62 (24): 11416–22. doi:10.1021/acs.jmedchem.9b00937.